The University of Glasgow, with assistance from colleagues at Lancaster University, the University of Oxford and the University of Warwick, have published a series of guided self-help booklets developed to support people with mild to moderate learning/intellectual disabilities during the COVID-19 outbreak.
Help us find a vaccine for COVID-19 by displaying a poster in your practice.
For a high-resolution PDF of the poster, please contact your local research facilitator.
Join the COVID-19 vaccine research registry.
The new NHS vaccine research registry will help NHS-approved researchers to get in touch with volunteers who can:
1. Sign up by adding their details to the registry.
2, Researchers will contact them with suitable studies and they can then decide to take part or not
Sign up at: nhs.uk/researchcontact
Accuracy of patient-owned blood pressure monitors compared to Omron PA350 monitor checker
This is a primary care based cross sectional survey, testing patients’ blood pressure (BP) monitors using the OMRON PA350 digital BP tester.
TAPS:Treatment of Aches and PainS Trial
The STarT Back trial showed that stratified care, based on matching treatment to prognosis (lw, medium, or high risk of ongoing problems), was clinically and cost effective.
TAPS is a flagship clinical trial to test if this approach also works for people with neck, shoulder, knee and multi-site pain (& back pain).
REACT (Relatives Education And Coping Toolkit) is an online peer-supported toolkit for relatives of people with psychosis or bipolar disorder which contains lots of information to help relatives, ideas of strategies to manage common problems, and stories from other relatives about their experiences.
Join Dementia Research (www.joindementiaresearch.nihr.ac.uk) is a nationwide online and telephone service where you can register your interest in participating in dementia research. Anyone 18 or over, with or without dementia, can register as a volunteer or sign-up for someone else, providing that you have their consent.
(Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease) is a major multi-centre trial of allopurinol 600mg daily versus no treatment added to usual therapy in patients aged 60 years and over with ischaemic heart disease. The aim is to establish whether allopurinol improves cardiovascular outcomes in this population.